Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 17, 2023, titled "Revision in Company s practice for making disclosures for product approvals".
Press Release Apr 17 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Earlier from Alembic Pharmaceuticals
- Press Release Mar 30 2023
- Press Release Mar 09 2023
- Press Release Mar 08 2023
- Press Release Mar 06 2023
- Press Release Mar 01 2023
Later from Alembic Pharmaceuticals
- Press Release May 05 2023
- Alembic Pharmaceuticals Limited Press Release May 10 2023
- Alembic Pharmaceuticals Limited Press Release Jul 03 2023
- Press Release Aug 04 2023
- Press Release Oct 02 2023
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals